Related references
Note: Only part of the references are listed.A phase II study of biweekly oxaliplatin plus S-1 combination chemotherapy as a first-line treatment for patients with metastatic or advanced gastric cancer in China
Cheng Xiao et al.
MEDICINE (2019)
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial
Hironori Ishigami et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings
Hironori Ishigami et al.
GASTRIC CANCER (2017)
Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PI)
Hironaga Satake et al.
ESMO OPEN (2017)
A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent
Y. Yonemura et al.
EJSO (2016)
Regional but fatal: Intraperitoneal metastasis in gastric cancer
Jia Wei et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Phase II study of intraperitoneal paclitaxel plus S-1/oxaliplatin for gastric cancer with peritoneal metastasis: SOX plus IP PTX trial
Yoshiyuki Fujiwara et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naive patients with advanced gastric cancer
Y. Yamada et al.
ANNALS OF ONCOLOGY (2015)
Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites
Joji Kitayama et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials
F. Coccolini et al.
EJSO (2014)
A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis
Hironori Yamaguchi et al.
CANCER (2013)
Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry
Atsushi Nashimoto et al.
GASTRIC CANCER (2013)
Randomized Phase III Study of 5-Fluorouracil Continuous Infusion vs. Sequential Methotrexate and 5-Fluorouracil Therapy in Far Advanced Gastric Cancer with Peritoneal Metastasis (JCOG0106)
Kuniaki Shirao et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2013)
A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer
Gun Min Kim et al.
EUROPEAN JOURNAL OF CANCER (2012)
Complications and Management of an Implanted Intraperitoneal Access Port System for Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Metastasis
Shigenobu Emoto et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients with Peritoneal Dissemination
Yoshiyuki Fujiwara et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
Xiao-Jun Yang et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Japanese classification of gastric carcinoma: 3rd English edition
GASTRIC CANCER (2011)
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis
H. Ishigami et al.
ANNALS OF ONCOLOGY (2010)
Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy
Olivier Glehen et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
Y. -K. Kang et al.
ANNALS OF ONCOLOGY (2009)
Efficacy of sequential methotrexate and 5-fluorouracil (MTX/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal dissemination
Masako Imazawa et al.
GASTRIC CANCER (2009)
Interval debulking surgery for advanced epithelial ovarian cancer: A Cochrane systematic review
Siriwan Tangjitgamol et al.
GYNECOLOGIC ONCOLOGY (2009)
Safety and Efficacy of Bidirectional Chemotherapy for Treatment of Patients With Peritoneal Dissemination From Gastric Cancer: Selection for Cytoreductive Surgery
Yutaka Yonemura et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie
S. -E. Al-Batran et al.
ANNALS OF ONCOLOGY (2008)
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Wasaburo Koizumi et al.
LANCET ONCOLOGY (2008)
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer
Sung Yong Oh et al.
ACTA ONCOLOGICA (2007)
Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients
Michiya Kobayashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
M Markman et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
